US SB2952 | 2021-2022 | 117th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on October 7 2021 - 25% progression, died in committee
Action: 2021-10-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a drug, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

FDA Modernization Act of 2021

Sponsors


History

DateChamberAction
2021-10-07SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB7667 (Related) 2022-06-09 - Received in the Senate.
SB4348 (Related) 2022-07-13 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.

Subjects


US Congress State Sources


Bill Comments

feedback